On Dec. 16, 2024, the Mayo Clinic announced the results of an innovative treatment approach that may offer…
On Dec. 4, 2024, The U.S. Food and Drug Administration (FDA) announced approved of AstraZeneca’s blockbuster drug Imfinzi…
On Nov. 21, 2024, a study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why…
On Oct. 28, 2024, HOPO Therapeutics announced that it has been awarded a contract valued at up to…
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…
On Apr. 30, 2024, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
On Sept. 6, 2023, the Markey Cancer Center (MCC) became Kentucky’s first and only National Cancer Institute (NCI)-Designated…
On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…
On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Mar. 23, 2023, the Fred Hutchinson Cancer Center (FHCRC) announced a new building in South Lake Union…
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…
On Oct. 15, 2021, Roche announced that the U.S. Food and Drug Administration (FDA) had approved Tecentriq (atezolizumab)…
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…
On Jan. 8, 2021, the American Cancer Society reported that the death rate from cancer in the U.S….
On Dec. 18, 2020, the the U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Tagrisso (osimertinib) as the…
On Nov. 24, 2020, Northwestern University researchers announced they had developed a new artificial intelligence (A.I.) platform that…
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…